A 7-year open-label study of clinical parameters and therapeutic goals in patients with type 1 Gaucher disease receiving treatment with velaglucerase alfa: Updating the long-term experience with velaglucerase alfa
2013
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI